[Field study on the therapeutic value of trasylol in traumatic shock].

Abstract

A report of the results of a multicenter study including 4686 patients concerning the therapeutic value of Trasylol (Aprotinin) in traumatic shock. The group treated additionally with Trasylol showed, beside a reduced overall mortality, a statistically significant reduction of mortality in those treated within the first 30 min after the injury. Surgery performed in the posttraumatic stage showed a lower mortality in the Trasylol group. The importance of a time factor in shock treatment and the effects of Trasylol in traumatic shock are emphasized.

• Authors: B Schneider, G Schnells, O Trentz, H Tscherne
• Journal: Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen (Chirurg) Vol. 47 Issue 4 Pg. 185-8 (Apr 1976) ISSN: 0009-4722 [Print] Germany
• Vernacular Title: Feldstudie über den therapeutischen Wert von Trasylol beim traumatischen Schock
• PMID: 1085692 (Publication Type: English Abstract, Journal Article)

Chemical References

• Aprotinin

Topics

• Aprotinin (administration & dosage, therapeutic use)
• Drug Evaluation
• Humans
• Prognosis
• Shock, Traumatic (drug therapy)
• Time Factors